Mefloquine-induced mania in a 22-year-old Chinese man [1]

Singapore Medical Journal

Volumn 47, Issue 6, 2006, Pages 549-550

  Chern, Tor Phern ^a   Yee, Lee Hon ^b   Tan, Chay Hoon ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LARIUM; MEFLOQUINE; OLANZAPINE; RISPERIDONE;

ANOREXIA; ATAXIA; BRAIN DISEASE; CHINESE; CLINICAL FEATURE; CONFUSION; CONVULSION; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FATIGUE; HUMAN; LETTER; MALARIA; MANIA; PHYSICAL EXAMINATION; PSYCHIATRIST; PSYCHOSIS; SINGAPORE; SLEEP DISORDER; TREMOR;

ACUTE DISEASE; ADULT; ANIMALS; ANTIMALARIALS; BIPOLAR DISORDER; CHLOROQUINE; DRUGS, NON-PRESCRIPTION; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; RISK FACTORS; RISPERIDONE; SINGAPORE;

EID: 33745152308     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Croft A, Garner P, Mefloquine to prevent malaria: a systematic review of trials. BMJ 1997; 315:1412-6.
2. White NJ. Mefloquine. BMJ 1994; 308:286-7.
3. Steffen R. Travel medicine - prevention based on epidemiological data. Trans R Soc Trop Med Hyg 1991; 85:156-62.
4. Larium (mefloquine). [product monograph] Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacists Associations, 2002:876-7.
5. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996; 313:525-8.
6. Comment in: BMJ 1996; 313:1552-4.
7. Piening RB, Young SA. Mefloquine-induced psychosis. Ann Emerg Med 1996; 27:792-3.
8. Bern JL, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 1992; 95:167-79.
9. Even C, Friedman S, Lanouar K. Bipolar disorder after mefloquine treatment. J Psychiatry Neurosci 2001; 26:252-3.